The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...

GSK plc has announced that the China National Medical Products Administration has accepted for review the new drug ...

The rate of CSEs during the pre-treatment and follow-up periods was the primary endpoint. Mepolizumab demonstrates real-world effectiveness in reducing exacerbations in patients with severe asthma and ...

Recent medical research reveals promising developments in the treatment of patients suffering ... focused specifically on their effects on COPD exacerbations among diabetic patients.

SODIUM-GLUCOSE cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) are associated with a reduced risk of moderate or severe chronic obstructive pulmonary ...

Treatment depends on what type of lung cancer you have and how advanced it is. Sometimes, doctors can do surgery to remove a tumor if the disease hasn’t spread. You may also get radiation ...

Background Maintenance and reliever therapy (MART) with inhaled corticosteroid (ICS)/formoterol effectively reduces exacerbations in asthma. We aimed to investigate ...

H.I.V. treatment and services were funded through the President’s Emergency Plan for AIDS Relief, or PEPFAR, a $7.5 billion program that was frozen along with all foreign aid on Mr. Trump’s ...

Treatment can often successfully manage symptoms of COPD, but it’s a serious condition. Current treatments for COPD cannot repair the damage to your lungs, but some treatments may reduce your ...

Spirometry was performed to American Thoracic Society guidelines. Transfer factor of ... corticosteroid and/or antibiotic treatment during admission in the ‘during an exacerbation’ COPD group. Further ...

Summary: Home nocturnal non-invasive ventilation in patients with COPD and chronic hypercapnic respiratory failure improves survival and reduces hospitalizations. Summary: Frequent respiratory ...

Death from all causes and deaths attributed to COPD were similar between treatment and placebo groups ... This study showed that, in COPD exacerbations, two weeks of corticosteroid therapy ...